Revelation Biosciences Inc (REVB)
1.86
-0.09
(-4.62%)
USD |
NASDAQ |
May 16, 16:00
1.94
+0.08
(+4.30%)
After-Hours: 20:00
Revelation Biosciences Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
Cardiff Oncology Inc | 0.00 |
Ocular Therapeutix Inc | 0.1629 |
Ocugen Inc | 0.0935 |
Cue Biopharma Inc | 0.2399 |
Solid Biosciences Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 14.70M |
Total Liabilities (Quarterly) | 5.228M |
Shareholders Equity (Quarterly) | 9.473M |